Harrow (HROW) Cash & Current Investments (2010 - 2026)
Harrow (HROW) posted quarterly Cash & Current Investments of $94.6 million for Q1 2026, up 41.84% year-over-year from $66.7 million in Q1 2025, and up 29.78% quarter-over-quarter from $72.9 million in Q4 2025.
Harrow (HROW) Cash & Current Investments (2010 - 2026) Analysis & Trends
Harrow's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $94.6 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 41.84% year-over-year to $94.6 million; the TTM figure through Mar 2026 stood at $94.6 million (up 41.84% YoY), while the FY2025 annual figure was $72.9 million, up 54.35% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $94.6 million, up from $72.9 million in the prior quarter.
- The five-year high for Cash & Current Investments was $101.9 million in Q4 2022, with the low at $26.9 million in Q1 2023.
- The 5-year median for Cash & Current Investments is $71.0 million (2024), against an average of $64.4 million.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments soared 677.83% in 2022, then sank 46.87% in 2023.
- Harrow's Cash & Current Investments stood at $101.9 million in 2022, then retreated by 18.74% to $82.8 million in 2023, then plunged by 42.91% to $47.2 million in 2024, then jumped by 54.35% to $72.9 million in 2025, then rose by 29.78% to $94.6 million in 2026.
- Business Quant data shows HROW's Cash & Current Investments at $94.6 million in Q1 2026, $72.9 million in Q4 2025, and $74.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 164.00 Mn |
| 10 | Harrow | 1.59 Bn | 1.51 Bn | 50.36 Mn | 83.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.89 Mn |
| Mar 31, 2026 | 94.64 Mn |
| Dec 31, 2025 | 72.93 Mn |
| Sep 30, 2025 | 74.29 Mn |
| Jun 30, 2025 | 52.96 Mn |
| Mar 31, 2025 | 66.73 Mn |
| Dec 31, 2024 | 47.25 Mn |
| Sep 30, 2024 | 72.60 Mn |
| Jun 30, 2024 | 70.97 Mn |
| Mar 31, 2024 | 75.97 Mn |
| Dec 31, 2023 | 82.77 Mn |
| Sep 30, 2023 | 73.88 Mn |
| Jun 30, 2023 | 29.67 Mn |
| Mar 31, 2023 | 26.88 Mn |
| Dec 31, 2022 | 101.86 Mn |
| Sep 30, 2022 | 49.12 Mn |
| Jun 30, 2022 | 51.63 Mn |
| Mar 31, 2022 | 50.59 Mn |
| Dec 31, 2021 | 50.67 Mn |
| Sep 30, 2021 | 67.85 Mn |